Department of Internal Medicine I Cardiology University Hospital Würzburg Würzburg Germany.
Comprehensive Heart Failure Centre University and University Hospital Würzburg Germany.
J Am Heart Assoc. 2021 Feb 2;10(3):e017822. doi: 10.1161/JAHA.120.017822. Epub 2021 Jan 26.
Background Prospective longitudinal follow-up of left ventricular ejection fraction (LVEF) trajectories after acute cardiac decompensation of heart failure is lacking. We investigated changes in LVEF and covariates at 6-months' follow-up in patients with a predischarge LVEF ≤40%, and determined predictors and prognostic implications of LVEF changes through 18-months' follow-up. Methods and Results Interdisciplinary Network Heart Failure program participants (n=633) were categorized into subgroups based on LVEF at 6-months' follow-up: normalized LVEF (>50%; heart failure with normalized ejection fraction, n=147); midrange LVEF (41%-50%; heart failure with midrange ejection fraction, n=195), or persistently reduced LVEF (≤40%; heart failure with persistently reduced LVEF , n=291). All received guideline-directed medical therapies. At 6-months' follow-up, compared with patients with heart failure with persistently reduced LVEF, heart failure with normalized LVEF or heart failure with midrange LVEF subgroups showed greater reductions in LV end-diastolic/end-systolic diameters (both <0.001), and left atrial systolic diameter (=0.002), more increased septal/posterior end-diastolic wall-thickness (both <0.001), and significantly greater improvement in diastolic function, biomarkers, symptoms, and health status. Heart failure duration <1 year, female sex, higher predischarge blood pressure, and baseline LVEF were independent predictors of LVEF improvement. Mortality and event-free survival rates were lower in patients with heart failure with normalized LVEF (=0.002). Overall, LVEF increased further at 18-months' follow-up (<0.001), while LV end-diastolic diameter decreased (=0.048). However, LVEF worsened (=0.002) and LV end-diastolic diameter increased (=0.047) in patients with heart failure with normalized LVEF hospitalized between 6-months' follow-up and 18-months' follow-up. Conclusions Six-month survivors of acute cardiac decompensation for systolic heart failure showed variable LVEF trajectories, with >50% showing improvements by ≥1 LVEF category. LVEF changes correlated with various parameters, suggesting multilevel reverse remodeling, were predictable from several baseline characteristics, and were associated with clinical outcomes at 18-months' follow-up. Repeat hospitalizations were associated with attenuation of reverse remodeling. Registration URL: https://www.controlled-trials.com; Unique identifier: ISRCTN23325295.
缺乏对心力衰竭急性心功能失代偿后左心室射血分数(LVEF)轨迹的前瞻性纵向随访。我们研究了在出院时 LVEF≤40%的患者中,6 个月随访时 LVEF 和协变量的变化,并通过 18 个月随访确定了 LVEF 变化的预测因素及其预后意义。
跨学科网络心力衰竭计划参与者(n=633)根据 6 个月随访时的 LVEF 分为亚组:正常 LVEF(>50%;射血分数正常心力衰竭,n=147);中间范围 LVEF(41%-50%;射血分数中间范围心力衰竭,n=195),或持续降低的 LVEF(≤40%;射血分数持续降低心力衰竭,n=291)。所有患者均接受了指南指导的医学治疗。在 6 个月随访时,与射血分数持续降低心力衰竭患者相比,射血分数正常心力衰竭或射血分数中间范围心力衰竭亚组的左心室舒张末期/收缩末期直径(均<0.001)、左心房收缩末期直径(=0.002)明显减小,室间隔/后壁舒张末期厚度(均<0.001)明显增加,舒张功能、生物标志物、症状和健康状况明显改善。心力衰竭持续时间<1 年、女性、较高的出院前血压和基线 LVEF 是 LVEF 改善的独立预测因素。射血分数正常心力衰竭患者的死亡率和无事件生存率较低(=0.002)。总体而言,LVEF 在 18 个月随访时进一步增加(<0.001),而左心室舒张末期直径减小(=0.048)。然而,在 6 个月随访和 18 个月随访之间因心力衰竭再次住院的射血分数正常心力衰竭患者中,LVEF 恶化(=0.002),左心室舒张末期直径增加(=0.047)。
急性收缩性心力衰竭心功能失代偿的 6 个月幸存者表现出不同的 LVEF 轨迹,>50%的患者至少提高了 1 个 LVEF 类别。LVEF 变化与多种参数相关,提示存在多层次的逆重构,可从几个基线特征预测,并与 18 个月随访时的临床结局相关。再次住院与逆重构减弱有关。